Bioorganic and Medicinal Chemistry Letters p. 4893 - 4898 (2015)
Update date:2022-08-06
Topics:
Cox, Christopher D.
Hostetler, Eric D.
Flores, Broc A.
Evelhoch, Jeffrey L.
Fan, Hong
Gantert, Liza
Holahan, Marie
Eng, Waisi
Joshi, Aniket
McGaughey, Georgia
Meng, Xiangjun
Purcell, Mona
Raheem, Izzat T.
Riffel, Kerry
Yan, Youwei
Renger, John J.
Smith, Sean M.
Coleman, Paul J.
Phosphodiesterase 10A (PDE10A) inhibition has recently been identified as a potential mechanism to treat multiple symptoms that manifest in schizophrenia. In order to facilitate preclinical development and support key proof-of-concept clinical trials of novel PDE10A inhibitors, it is critical to discover positron emission tomography (PET) tracers that enable plasma concentration/PDE10A occupancy relationships to be established across species with structurally diverse PDE10A inhibitors. In this Letter, we describe how a high-throughput screening hit was optimized to provide [11C]MK-8193 (8j), a PET tracer that supports the determination of plasma concentration/PDE10A occupancy relationships for structurally diverse series of PDE10A inhibitors in both rat and rhesus monkey.
View MoreBeyond Pharmaceutical Co., Ltd
Contact:+86-571-8195-3185
Address:No. 13-1, Liansheng Road, Yuhang District
Hebei Think-Do Environment Co., Ltd
website:http://www.thinkdo-environment.com
Contact:0311-86510809
Address:No 6, Shilian Middle Street, Circular Chemical Industry Park
Contact:86-532-68629711 13780605697
Address:NO 220 YANAN 3 ROAD,(POST ADMINISTRATION BUILDING),QINGDAO,CHINA
Hangzhou GreenCo Science & Technology Co., Ltd.
Contact:86-571-88257303
Address:1713 Room,Jingui Building,Gudun Road,Xihu District,Hangzhou,China
Contact:86-27-84888681
Address:Wuhan economic & technology development zone
Doi:10.1016/j.ejmech.2010.07.059
(2010)Doi:10.1002/chem.201000828
(2010)Doi:10.1039/b925562a
(2010)Doi:10.1021/jo00293a049
(1990)Doi:10.1016/j.ica.2010.05.051
(2010)Doi:10.1021/jo1016458
(2010)